BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38469242)

  • 1. Predictive value of volumetric parameters based on
    Li Y; Chen J; Wang X; Yang P; Yang J; Zhao Q; Li J
    Front Oncol; 2024; 14():1335205. PubMed ID: 38469242
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Dong S; Li Y; Chen J; Li Y; Yang P; Li J
    Front Oncol; 2022; 12():1025930. PubMed ID: 36568229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of PSMA-PET derived volumetric parameters in initial risk stratification and prediction of prostate cancer metastasis - a head-to-head comparison of the radiotracers 18F-PSMA-1007 and 68Ga-PSMA-11.
    Chandekar KR; Satapathy S; Singh H; Kumar R; Kumar S; Kakkar N; Mittal BR; Singh SK
    Nucl Med Commun; 2024 Jun; ():. PubMed ID: 38932503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 68Ga-PSMA PET/CT with volumetric parameters for staging of prostate cancer patients.
    Aksu A; Karahan Şen NP; Tuna EB; Aslan G; Çapa Kaya G
    Nucl Med Commun; 2021 May; 42(5):503-509. PubMed ID: 33560717
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Wang Z; Zheng A; Li Y; Dong W; Liu X; Yuan W; Gao F; Duan X
    Front Oncol; 2021; 11():759053. PubMed ID: 34778079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Xie Y; Li C; Zhang L; Zang S; Yu F; Wang S; Wang F
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1143-1148. PubMed ID: 36073212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Analysis of Volumetric
    Mutevelizade G; Parlak Y; Sezgin Arıkbası C; Gümüşer G; Sayit E
    Mol Imaging Radionucl Ther; 2024 Jun; 33(2):68-76. PubMed ID: 38949389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and prospective validation of an SUV
    Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W
    Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of
    Hong JJ; Liu BL; Wang ZQ; Tang K; Ji XW; Yin WW; Lin J; Zheng XW
    EJNMMI Res; 2020 Nov; 10(1):138. PubMed ID: 33169183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations of the
    Karyagar SS; Karyagar S; Guven O
    Hell J Nucl Med; 2020; 23(2):120-124. PubMed ID: 32716402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of
    Wang T; Zhao L; Qiao W; Sun N; Zhao J; Xing Y
    Front Oncol; 2023; 13():1165694. PubMed ID: 37333816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Ga-68 PSMA PET/CT Scan on Differentiating of Oligometastatic and High Risk Prostate Cancer.
    Erdoğan M; Özkan EE; Öztürk SA; Yıldız M; Şengül SS
    Mol Imaging Radionucl Ther; 2020 Oct; 29(3):98-104. PubMed ID: 33094572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the value of
    Luo L; Zheng A; Chang R; Li Y; Gao J; Wang Z; Duan X
    Cancer Imaging; 2023 Nov; 23(1):108. PubMed ID: 37924154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental Impact of [
    Szigeti F; Schweighofer-Zwink G; Meissnitzer M; Hauser-Kronberger C; Hitzl W; Kunit T; Forstner R; Pirich C; Beheshti M
    Mol Imaging Biol; 2022 Feb; 24(1):50-59. PubMed ID: 34519966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of integrated
    Zeng Y; Leng X; Liao H; Jiang G; Chen P
    Prostate Int; 2022 Jun; 10(2):108-116. PubMed ID: 35510079
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Yang J; Li J; Xiao L; Zhou M; Fang Z; Cai Y; Tang Y; Hu S
    Cancer Imaging; 2023 Sep; 23(1):81. PubMed ID: 37667341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Ga
    Erdogan M; Sengul SS; Cetin B; Avcı M; Yagci S; Ozkoç I; Barikan DE; Yildiz M
    Ann Nucl Med; 2022 Jun; 36(6):562-569. PubMed ID: 35397091
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.